user avatar
Matthew Shun-Shin
@mshunshin
I've moved to Bluesky: matthew.shun-shin.com Clinical Senior Lecturer and Consultant Cardiologist
London, England
matthew.shun-shin.com
Joined August 2011
433
Following
869
Followers
Posts
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    Jul 29, 2018
    Replying to @ProfDFrancis
    Top tip for fellows: If you are unable to freely access a PDF of a study say, conducted using public money, written by freely by researchers, and peer-reviewed for free by others… Under no circumstance copy the Pubmed ID and then paste into sci-hub. tw to easily download
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    Dec 10, 2018
    All I want for Christmas is a.... #dontdisthehis @JACCJournals paper onlinejacc.org/content/72/24/… get it while it’s hot! His vs BiV in LBBB @DrAhranArnold @Dr_Keene
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    Jan 29, 2024
    ACC24 with two trials from Imperial TELE-ACS (@rkhamis), and ORBITA-COSMIC (@rallamee - who is telling me to stop tweeting and get back to R).
    user avatar
    American College of Cardiology
    @ACCinTouch
    Jan 29, 2024
    🚨 #ACC24 Breaking News 🚨 The ACC.24 Late-Breaking Clinical Trials are out! Some of the trials being presented are: ◼️ RELIEVE-HF ◼️ EMPACT-MI ◼️ AEGIS-II ◼️ VICTORION-INITIATE ◼️ Step-HFpEF Dm ◼️ TELE-ACS Learn more & see the full list of trials: bit.ly/47UvZYt
    00:00
    5.9K
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    Jul 25, 2017
    Replying to @mshunshin
    Thu 2nd Nov 2017. How to; tips and tricks; and, most excitingly - His Pacing for Heart Failure #UKHisPacing #dontdisthehis
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    Jul 3, 2017
    .@RichardLehman1 's latest reviews features our SAMSON trial samson-trial.org - n-of-1 trial for statin side effects.
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    Nov 11, 2023
    It’s out.
    user avatar
    NEJM
    @NEJM
    Nov 11, 2023
    Presented at #AHA23: ORBITA-2 trial: In patients with stable angina who were receiving little or no antianginal medication and had documented ischemia, PCI resulted in a better health status with respect to angina than placebo at 12 weeks. Full results: nej.md/3u21tO2
    1.8K
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    May 19, 2018
    Replying to @ProfDFrancis and @drjohnm
    I can trump your video - with this video from when the UK rolled out thrombolysis for acute stroke. (Watch with sound). I used it in a presentation in 2006. Anyway - the data for thrombectomy looks good - I think the UK is working out how/who to provide the service @LCC_DrMalik
    00:00
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    Jul 20, 2018
    Replying to @venkmurthy @f2harrell and @NEJM
    1) Here is an R-notebook with the data and the “rms” style 7-level ordinal analysis. Hope I got it right! notebooks.azure.com/anon-jkvmiw/li… 2) You can customise the analysis to fit your personal ordering of the mRS (i.e. you may consider some states worse than death).
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    Aug 28, 2017
    Quick renal denervation meta-analysis. ABPM. Sham. From me in a BCN bar and @j_p_howard in LDN. @DrAfzalSohaib @escardio #ESCcongress
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    Nov 2, 2017
    I often await Larry’s reviews almost as much as the trials. Some great comments and thoughts.
    user avatar
    Larry Husten
    @cardiobrief
    Nov 2, 2017
    Diving Deep Into The ORBITA Trial cardiobrief.org/2017/11/02/div…
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    Aug 1, 2017
    Two failed LV lead attempts. #UKHisPacing - 15 minutes to pace His - narrowed QRS by 30ms. #dontdisthehis # @ImperialEP @DrAfzalSohaib
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    Nov 3, 2017
    It is well worth the 59.5Mb download.
    user avatar
    Matthew Shun-Shin
    @mshunshin
    Nov 3, 2017
    This - angio images of all 200 lesions available in appendix
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    May 10, 2018
    Replying to @drjohnm @skathire and 6 others
    In retrospect there was no point in changing the primary endpoint from mortality.
  • user avatar
    Matthew Shun-Shin
    @mshunshin
    Aug 22, 2018
    Interesting editorial (and paper in circ). Top tip for fellows. Don’t google the first two references in it for the back story. It’s not at all interesting.
    user avatar
    Circulation
    @CircAHA
    Aug 22, 2018
    #Editorial: Undeniable evidence that the adult mammalian heart lacks an endogenous regenerative stem cell ow.ly/X1uE30luSY2